Abstract
Hydroxychloroquine has been used worldwide as a first-line treatment for patients hospitalized with COVID-19. Little is known about COVID-19 and its effects on patients with congenital red blood cell disorders. We report a case of haemolytic anaemia in a 32-year-old patient and a fortuitous highlighting of G6PD deficiency. We reviewed the literature to assess the risk of hydroxychloroquine use in this context.
Author supplied keywords
Cite
CITATION STYLE
Mastroianni, F., Colombie, V., Claes, G., Gilles, A., Vandergheynst, F., & Place, S. (2020). Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 complicated by haemolytic anaemia: Culprit or innocent bystander? European Journal of Case Reports in Internal Medicine, 7(9). https://doi.org/10.12890/2020_001875
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
